HCPCS C9073
Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Retired codeChemotherapeutic Agent0 hospitals with prices
This code is retired. Some hospitals still list it. CMS replaced it with HCPCS Q2053.
What Washington hospitals publish for this code
No Washington hospital publishes a dollar price for this code yet.
Medicare (traditional) reference
CMS publishes no national amount for this code.